BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32322590)

  • 1. Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix.
    Zong L; Zhang Q; Zhou Y; Kong Y; Yu S; Chen J; Zhang Y; Xiang Y
    J Immunol Res; 2020; 2020():1283632. PubMed ID: 32322590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of B7 family checkpoint proteins in cervical cancer.
    Zong L; Gu Y; Zhou Y; Kong Y; Mo S; Yu S; Xiang Y; Chen J
    Mod Pathol; 2022 Jun; 35(6):786-793. PubMed ID: 34848831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma.
    Wang Y; Deng J; Wang L; Zhou T; Yang J; Tian Z; Yang J; Chen H; Tang X; Zhao S; Zhou L; Tong A; Xu J
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune checkpoints CTLA-4 and PD-L1 in carcinomas of the uterine cervix.
    Karpathiou G; Chauleur C; Mobarki M; Peoc'h M
    Pathol Res Pract; 2020 Jan; 216(1):152782. PubMed ID: 31862202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC).
    Carvajal-Hausdorf D; Altan M; Velcheti V; Gettinger SN; Herbst RS; Rimm DL; Schalper KA
    J Immunother Cancer; 2019 Mar; 7(1):65. PubMed ID: 30850021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
    Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL
    Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression and Prognostic Value of B7 Family Immune Checkpoints in Pancreatic Neuroendocrine Tumors.
    Mo S; Zong L; Chen X; Ban X; Li M; Lu Z; Yu S; Chen J
    Arch Pathol Lab Med; 2023 Feb; 147(2):193-201. PubMed ID: 35671167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer.
    Enwere EK; Kornaga EN; Dean M; Koulis TA; Phan T; Kalantarian M; Köbel M; Ghatage P; Magliocco AM; Lees-Miller SP; Doll CM
    Mod Pathol; 2017 Apr; 30(4):577-586. PubMed ID: 28059093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance.
    Huang C; Zhou L; Chang X; Pang X; Zhang H; Zhang S
    Oncol Rep; 2016 Apr; 35(4):2183-90. PubMed ID: 26848032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H4 Expression in Precancerous Lesions of the Uterine Cervix.
    Zhang Q; Zong L; Zhang H; Xie W; Yang F; Sun W; Cui B; Zhang Y
    Biomed Res Int; 2021; 2021():5857092. PubMed ID: 34651047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix.
    Heeren AM; Punt S; Bleeker MC; Gaarenstroom KN; van der Velden J; Kenter GG; de Gruijl TD; Jordanova ES
    Mod Pathol; 2016 Jul; 29(7):753-63. PubMed ID: 27056074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas.
    Reddy OL; Shintaku PI; Moatamed NA
    Diagn Pathol; 2017 Jun; 12(1):45. PubMed ID: 28623908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the immune checkpoint VISTA in breast cancer.
    Zong L; Mo S; Yu S; Zhou Y; Zhang M; Chen J; Xiang Y
    Cancer Immunol Immunother; 2020 Aug; 69(8):1437-1446. PubMed ID: 32266446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
    Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
    Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
    [No Abstract]   [Full Text] [Related]  

  • 15. VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer.
    Zong L; Zhou Y; Zhang M; Chen J; Xiang Y
    Cancer Immunol Immunother; 2020 Jan; 69(1):33-42. PubMed ID: 31781843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and Clinical Significance of Immune Checkpoint Regulator B7-H3 (CD276) in Human Meningioma.
    Deng J; Ma M; Wang D; Zhu H; Hua L; Sun S; Chen H; Cheng H; Qian ZR; Xie Q; Zhang T; Gong Y
    World Neurosurg; 2020 Mar; 135():e12-e18. PubMed ID: 31629137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
    Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
    Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1, B7-H3 and VISTA are highly expressed in gestational trophoblastic neoplasia.
    Zong L; Zhang M; Wang W; Wan X; Yang J; Xiang Y
    Histopathology; 2019 Sep; 75(3):421-430. PubMed ID: 31013360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAG-3, TIM-3 and VISTA Expression on Tumor-Infiltrating Lymphocytes in Oropharyngeal Squamous Cell Carcinoma-Potential Biomarkers for Targeted Therapy Concepts.
    Wuerdemann N; Pütz K; Eckel H; Jain R; Wittekindt C; Huebbers CU; Sharma SJ; Langer C; Gattenlöhner S; Büttner R; Speel EJ; Suchan M; Wagner S; Quaas A; Klussmann JP
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer.
    Xie X; Zhang J; Shi Z; Liu W; Hu X; Qie C; Chen W; Wang Y; Wang L; Jiang J; Liu J
    Front Immunol; 2020; 11():563044. PubMed ID: 33250890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.